Hetero Labs, one of Indias largest privately held drugmakers, aims to sell 1.5 million pens of generic weight-loss and diabetes drugs in the first year as it rolls out the products in more than 75 co… [+1636 chars]
Read Full Story
Hetero targets annual sales of 1.5 million Semaglutide pens in global roll-out
Posted on April 16, 2026 at 